development, safety and efficacy analysis of liquid state rabies
TRANSCRIPT
![Page 1: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/1.jpg)
DEVELOPMENT AND EFFICACY ANALYSIS OF
LIQUID STATE RABIES VACCINE FOR HUMAN
USE
Submitted by:
Balaganesh.K , Prashanth Kumar. K. 1OX06BT002 1OX06BT013.
External Guide:
S.Jagannathan, M.Sc, PGDBI, MBA, Ph.D(Pursuing)Assistant Research Officer,
PIIC, Coonoor.
![Page 2: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/2.jpg)
Contents:
![Page 3: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/3.jpg)
Abstract
In this set of review, the biochemical
estimation of magnesium chloride and
Trehalose by the D-HPTLC method will be
dealt along with the REFIT analysis of the anti-
sera , stability analysis of the samples and the
docking studies carried out in identifying the
component acting as a suitable stabilizer in
maintaining the native state of Ag will be found
out.
![Page 4: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/4.jpg)
Topics covered in last reviews
SRID has been performed for different samples which are obtained from
the TCARV section of the PIIC
The potency of the samples was estimated quantitatively from the results
of the SRID
Based on this potency value the sample which is having more potency was
selected for the further formulation
Haemagglutination , Formulation.
Biochemical estimations of all components used.
Animal studies (Production of primary & secondary antibodies,abnormal
toxicity tests)
![Page 5: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/5.jpg)
Methods and Materials
Further experimental studies conducted
upon the formulated vaccine samples were as
follows –
Biochemical estimation (contd) - Estimation of
magnesium chloride
HPTLC of Trehalose
REFIT analysis
In silico analysis of stabilizers used.
![Page 6: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/6.jpg)
SRID potency Check of the formulated Vaccine
samples.
The formulated Vaccine samples were
subjected for stability analysis via the SRID
method , conducted on a periodical basis in
the alternate days till the 7th day and later on
once in 5 days,.
The potency evaluation will be carried
out on a long term basis to ensure the efficacy
of the formulated vaccine samples.
![Page 7: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/7.jpg)
REFIT Analysis
![Page 8: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/8.jpg)
ESTIMATION OF MAGNESIUM CHLORIDE IN VACCINE
SAMPLE
![Page 9: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/9.jpg)
HPTLC Analysis of Trehalose content
ANALYSIS DETAILS
MOBILE PHASE : n-butanol-pyridine-water ( 8:4:3)
SPRAY REAGENT: N-(1-naphthyl)-ethylenediamine dihydrochloride in methanol
containing 3% sulphuric acid reagent (Bournias, 1980)
DETECTION : Bluish white colored fluorescent zones at UV 366nm
QUANTIFICATION OF RESULTS
Area of Sample x Concentration of Standard
The % of Trehalose = _____________________________________ x 95
Area of Standard x Concentration of Sample
![Page 10: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/10.jpg)
And the process was carried out in the steps mentioned as
follows
![Page 11: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/11.jpg)
Insilico analysis
Homology modeling of the Rabies Viral G-
Protein
G – Viral protein sequence was obtained and was
process for various steps and the appropriate template
was selected and whose pdb id was retrieved and the
modeling request was submitted through Swiss-
proteomics server using Spdbv
software.
![Page 12: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/12.jpg)
Docking of the modeled protein with various
stabilizers.
Receptor : Modeled Rabies Viral G Protein.
Ligands being –
Trehalose, Lactose,
Aluminum Phosphate,
Magnesium Chloride,
Human Albumin.
![Page 13: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/13.jpg)
Results and Discussion REFIT
REFIT Analysis
Table shows: Immune response analysis
Sl.N
o
Name of the Vaccines Booster
dosage
RFFIT (Rabies Neutralizing
antibodies in IU/ml)
14th Day 21st Day
1. PRVA 02/08 On 7th day 0.5 8.0
2. Local Reference (HO23) On 7th day ≥32.0 ≥32.0
3. TCARLV-A On 7th day 8.0 8.0
4. TCARLV-B On 7th day 2.0 32.0
5. TCARLV-C On 7th day 16.0 16.0
6. TCARLV-D On 7th day ≥32.0 32.0
![Page 14: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/14.jpg)
Fig. shows: Positive fluorescence indicating presence of antibody
The positive fluorescence indicating the presence of antibodies against
the administered Formulated Vaccine samples in the anti sera collected
from the animals subjected for immunization
![Page 15: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/15.jpg)
SRID Potency evaluation
A B
C D
A: 5th day
samples ( both
+4 and +34˚C)
B: 10th day
samples ( both
+4 and +34˚C)
C: 15th day
samples ( both
+4 and +34˚C)
D: 20th day
samples ( both
+4 and +34˚C)
![Page 16: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/16.jpg)
Chromatogra
m
code
Sample code Quantity
A Sample A 20µg in 1µL
T1Trehalose
standard150ng in 1.5µL
T2Trehalose
standard300ng in 3µL
T3Trehalose
standard450ng in 4.5µL
T4Trehalose
standard600ng in 6µL
T5Trehalose
standard750ng in 7.5µL
C Sample C 20µg in 1µL
D Sample D 20µg in 1µL
HPTLC ANALYSIS OF TREHALOSE CONTENTTable shows : Sample code for HPTLC
![Page 17: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/17.jpg)
3D Peak densitogram of all tracks scanned at 366nm
Using which the concentration of the
trehalose was
determined in
the formulated
samples A and
D.
![Page 18: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/18.jpg)
Table shows: Peak table for the analysed samples
Track Peak Rf Height Area Assigned substance
A 1 0.19 48.3 874.4 Trehalose
T1 1 0.19 46.5 1057.7 Trehalose standard
T2 1 0.19 47.6 948.1 Trehalose standard
T3 1 0.19 59.4 1046.1 Trehalose standard
T4 1 0.19 33.2 483.8 Trehalose standard
T5 1 0.19 40.7 554.0 Trehalose standard
C 1 0.19 44.2 777.8 Trehalose
D 1 0.20 42.5 632.5 Trehalose
![Page 19: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/19.jpg)
Chromatogram
Fig showing Chromatogram for
TCARLV A TCARLV C TCARLV
D
![Page 20: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/20.jpg)
QUANTIFICATION OF RESULTS
Area of Sample x Concentration of StandardThe % of Trehalose =
_____________________________________ x 95Area of Standard x Concentration of Sample
874.4 0.45
Sample A = ________x _____ x 99 = 1.86%
1046.1 20
Sample C = 1.65%
Sample D = 1.35%
![Page 21: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/21.jpg)
Magnesium chloride estimation
Samples Volume
of
std/unkn
own
taken
(ml)
Conc. Of
MgCl2
(µg)
Volume
of
distilled
H2O (ml)
Volume
of
Gumgha
patti (ml)
Volume
of Titon
yellow
(ml)
Volume
of 4N
NaOH
(ml)
Volume
of CaCl2
(ml)
OD at
540nm
Blank - - 2.5 1.0 1.0 2.0 1.0 0.00
S1 0.2 200 2.3 1.0 1.0 2.0 1.0 0.152
S2 0.4 400 2.1 1.0 1.0 2.0 1.0 0.311
S3 0.6 600 1.9 1.0 1.0 2.0 1.0 0.445
S4 0.8 800 1.7 1.0 1.0 2.0 1.0 0.680
S5 1.0 1000 1.5 1.0 1.0 2.0 1.0 0.780
Sample
B
1.0 1.0 1.0 2.0 1.0 0.708Concentration of MgCl2 = (Test OD/ Std. OD) x Concentration of standard x
(1/1.0)
= (0.708/0.608) x 800
=832.94 µg
=0.83 mg/SHD.
![Page 22: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/22.jpg)
Docking Results
Ligand
Name
E Total E Shape E force E air V shape V clash
Human
Albumin
-499.03 -499.03 0.00 0.00 0.00 0.00
Lactose -183.81 -183.81 0.00 0.00 0.00 0.00
Trehalose -171.18 -171.18 0.00 0.00 0.00 0.00
MgCl2 - 144.37 -144.37 0.00 0.00 0.00 0.00
AlPO4 -110.33 -110.33 0.00 0.00 0.00 0.00
From which, it can be conferred
that Human Albumin acts a
better stabilizing agent in the
formulated samples, and
followed by the rest.
![Page 23: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/23.jpg)
CONCLUSION
Purified rabies viral antigens obtained from the TCARV section of Pasteur Institute of India, Coonoor, were analysed for their safety, potency and purity by various IPQC tests. Based on the values sample PRVA 02/08 shows some very good results when compared to the other samples. PRVA 02/08 was used to formulate four kind of liquid rabies vaccines with different stabilizers and additives and are named as TCARLV-A, TCARLV-B, TCARLV-C and TCARLV-D.
All the formulated vaccine samples were analysed for their safety by abnormal toxicity studies in Mice and Guinea pigs. The constituents of the vaccines were estimated biochemically. The potency of the vaccines was estimated by RIFFIT method and all the vaccine samples shows good amount of potency, especially vaccine TCARLV-B and TCARLV-D shows greater amount of potency.
Our contribution however opens the door for further investigation and hopefully might also paved the way for further research. It is a valuable tool to fight against rabies in man.
![Page 24: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/24.jpg)
Bibliography
Morefield GL, sokolovska A, Jiang D, et al., 2005. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23; 1588-1595.
Nickerson, et al (1976) Colorimetric estimation of Lactose and its hydrolytic products, J. Dairy Science 59, No 3, page386.
PathScan® Sandwich ELISA Protocol.
Tsiang H; (1993).Pathophysiology of rabies virus infection of the nervous systemIn:Adv. Virus Res; 42: 375-412.Cited: Plotkin S.A; Rupprecht C.E. and Koprowski M; (1999).
WHO; (1992).Expert committee on Rabies. Diagnosis, 8th Report.WHO, Geneva.In:Tech. Rep. Ser.NO.824; 1-84.
Wiktor. T.J.; Macfarlan, R.I.; Forggin, C.M.; Koprowiski, H.; (1984).Antigenic analysis of rabies and Mokola Virus from Zimbabwe using monoclonal antibodies.In: Dev. Biol.Stand;57: 199-211Cited from: Dietzschold, B.; Rupprecht, C.E.; Fu, Z.F.; and Koprowiski, H.(1996).
Wunner, W.H.; (1992).Rabies. In: Encyclopedia of Microbiology, 3:497-508.
Jagan nathan.S. et al., 2008. Filtration techniques in Vaccine manufacturing., Journal of advanced Biotechnology 07(02); 37-41.
![Page 25: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/25.jpg)
Acknowledgement
For the first we would like to thank
The principal, The Oxford College of Engineering and Head of Department, Biotechnology and all the faculty for providing us the permission and support as well as the opportunity to carry out this project at PIIC.
Followed by Pasteur Institute of India, Coonoor for providing us with all the facilities required for the execution of project and for its stupendous cooperation as well.
![Page 26: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/26.jpg)
And also we would like to thank,
Dalmia Centre for Research and Development
Coimbatore, India.
For their co-operation
and full-fledged assistance in quantifying the
amount of Trehalose present in the formulated
samples A, C and D.
And finally, would like to thank all my friends
for all their support and for being an inspiration
forever.
![Page 27: Development, safety and efficacy analysis of liquid state rabies](https://reader033.vdocuments.us/reader033/viewer/2022042615/55a6acb91a28abd5018b4869/html5/thumbnails/27.jpg)